Press Releases

JERUSALEM, Nov. 26, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced its financial results for the quarter ended September 30, 2019.

TEL AVIV, Israel, Nov. 26, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that it will host an investor breakfast meeting on Thursday, December 5, 2019 at the Convene Conference Center near Grand Central Term

TEL AVIV, Israel, Nov. 26, 2019 /PRNewswire/ -- Alpha Tau Medical is pleased to announce the publication of the results of its first clinical trial of Alpha DaRT™, a novel alpha radiation cancer treatment, in the International Journal of Radiation Oncol

SAN JOSE, Calif., Nov. 26, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against canc

NEW PROVIDENCE, N.J., Nov. 26, 2019 /PRNewswire/ -- The PromptCare Companies ("PromptCare" or the "Company"), a leading regional provider of respiratory therapy and specialty infusion services, announced it has acquired Hollywood Medical Supply ("Hollywood") from owner and CEO, Robert Lichtenstein. The

BENGALURU, India, Nov. 26, 2019 /PRNewswire/ --  Omega Healthcare Management Services, a leading provider of Revenue Cycle Management process and Analytics Solutions for the healthcare sector, today announced the appointment of Sumit Sachdeva as Chief Grow

STAINES-UPON-THAMES, United Kingdom, Nov. 26, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced findings from

IRVINE, Calif., Nov. 26, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to present at the following two investor conferences in December:

IRVING, Texas and MINNEAPOLIS, Nov. 26, 2019 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that the University of Minnesota has become the 31st member of its

LANSDOWNE, Pa., Nov. 26, 2019 /PRNewswire/ -- In response to the nation's opioid crisis and increased demand for treatment, Recovery Centers of America (RCA) announced the opening of its third Medication for Addiction Treatment ("MAT") facility, the first in Pennsylvania, in Lansdowne.